Natco Pharma Limited (NSE: NATCOPHARM), ISIN INE987B01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NATCOPHARM last traded at ₹935.70 (+0.01%), with a 52-week range of ₹789.30 to ₹1226.10 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 49.42%, FIIs 16.99%, DIIs 5.62%, mutual funds 1.92%.
EquiSense Score (ECS): 36/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.